Patents by Inventor Denis Brouillette

Denis Brouillette has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction
    Patent number: 7323461
    Abstract: The present invention relates to the use of the dye methylene blue (MB) or a related compound to prevent or reverse an exaggerated hemodynamic reaction in animals in need thereof, including humans. More specifically, the present invention concerns the use of MB or a related compound to prevent or reverse hypotension, unstable angina, myocardial infarction or shock caused by the concomitant ingestion of a phosphodiesterase inhibitor, such as sildenafil citrate, and a NO-donor, such as L-arginine, or an organic nitrate, such as nitroglycerin.
    Type: Grant
    Filed: March 28, 2003
    Date of Patent: January 29, 2008
    Assignee: Montreal Heart Institute
    Inventors: Martin Juneau, Jean-François Tanguay, Denis Brouillette
  • Use of methylene blue and related compounds to prevent or reverse an exaggerated hemodynamic reaction
    Publication number: 20030219495
    Abstract: The present invention relates to the use of the dye methylene blue (MB) or a related compound to prevent or reverse an exaggerated hemodynamic reaction in animals in need thereof, including humans. More specifically, the present invention concerns the use of MB or a related compound to prevent or reverse hypotension, unstable angina, myocardial infarction or shock caused by the concomitant ingestion of a phosphodiesterase inhibitor, such as sildenafil citrate, and a NO-donor, such as L-arginine, or an organic nitrate, such as nitroglycerin.
    Type: Application
    Filed: March 28, 2003
    Publication date: November 27, 2003
    Inventors: Martin Juneau, Jean-Francois Tanguay, Denis Brouillette